BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29773002)

  • 1. Clinicopathological Characteristics and Prognoses of Elderly Gastric Cancer Patients after R0 Resection: A Multicenter Study in China.
    Ma X; Ren D; Kan J; Zheng F; Zhang S; Zhang Y; Li Y; Liu Z; Ye L; Shen G; Wang Z; Zhao F; Ahmad R; Zhao J
    J Environ Pathol Toxicol Oncol; 2018; 37(1):81-91. PubMed ID: 29773002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardia and Non-Cardia Gastric Cancer Have Similar Stage-for-Stage Prognoses After R0 Resection: a Large-Scale, Multicenter Study in China.
    Zhao J; Zhao J; Du F; Zhang Y; Shen G; Zhu H; Ji F; Ma F; Dong L; Kan J; Zheng F; Chen H; Wang Z; Xu B
    J Gastrointest Surg; 2016 Apr; 20(4):700-7. PubMed ID: 26831062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China.
    Shen GS; Zhao JD; Zhao JH; Ma XF; Du F; Kan J; Ji FX; Ma F; Zheng FC; Wang ZY; Xu BH
    World J Gastroenterol; 2016 Jun; 22(23):5406-14. PubMed ID: 27340357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
    Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
    BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of High Altitude on Clinicopathological Features and Prognosis after R0 Resection for Gastric Cancer: A Population-Based Multicenter Study.
    Zhao J; Du F; Zhang Y; Zhu H; Dong L; Shen G; Zheng F; Chen H; Zhao J; Ji F; Luo Y; Ma F; Wang Z; Xu B
    J Environ Pathol Toxicol Oncol; 2017; 36(1):1-14. PubMed ID: 28605327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of Young Survivors of Gastric Cancer in China and the U.S.: Determining Long-Term Outcomes Based on Conditional Survival.
    Chen QY; Zhong Q; Wang W; Chen S; Li P; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng HL; Liu ZY; Zheng CH; Peng JS; Zhou ZW; Huang CM
    Oncologist; 2019 Jun; 24(6):e260-e274. PubMed ID: 30470692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-adjuvant chemotherapy leukocyte count may predict the outcome for advanced gastric cancer after radical resection.
    Pei D; Zhu F; Chen X; Qian J; He S; Qian Y; Shen H; Liu Y; Xu J; Shu Y
    Biomed Pharmacother; 2014 Mar; 68(2):213-7. PubMed ID: 24581723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods.
    Kim DH; Kim SM; Hyun JK; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    Ann Surg Oncol; 2013 Jul; 20(7):2317-27. PubMed ID: 23677605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is Adjuvant Chemotherapy Necessary after R0 Resection for pCR or ypStage I Patients with Gastric Cancer ?].
    Yamamoto K; Nishikawa K; Hirao M; Fujitani K; Tsujinaka T; Uemura M; Miyake M; Hama N; Miyamoto A; Miyazaki M; Omiya H; Ikeda M; Takami K; Nakamori S; Sekimoto M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1929-1932. PubMed ID: 28133179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: A propensity score matching analysis.
    Kanda M; Murotani K; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Surgery; 2015 Dec; 158(6):1573-80. PubMed ID: 26120068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy.
    Shitara K; Chin K; Yoshikawa T; Katai H; Terashima M; Ito S; Hirao M; Yoshida K; Oki E; Sasako M; Emi Y; Tsujinaka T
    Gastric Cancer; 2017 Jan; 20(1):175-181. PubMed ID: 26626800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
    Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
    J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and Effectiveness of Gastrectomy for Elderly Gastric Cancer Patients.
    Otowa Y; Okamoto S; Fujinaka R; Arai K; Murata K; Mii Y; Kakinoki K; Oka S; Kuroda D
    In Vivo; 2019; 33(4):1307-1311. PubMed ID: 31280223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term outcome and analysis of prognostic factors in 114 cases of postoperative stage III gastric cancer].
    Zhang Y; Ma LW
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):863-6. PubMed ID: 24447487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram.
    Strong VE; Song KY; Park CH; Jacks LM; Gonen M; Shah M; Coit DG; Brennan MF
    Ann Surg; 2010 Apr; 251(4):640-6. PubMed ID: 20224369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathological characteristics and prognostic factors in patients with stage III gastric cancer].
    Xu Y; Sun Z; Wang ZN; Xu HM
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):125-8. PubMed ID: 22368016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Gastric Cancer Surgery in Elderly Patients.
    Wakahara T; Ueno N; Maeda T; Kanemitsu K; Yoshikawa T; Tsuchida S; Toyokawa A
    Oncology; 2018; 94(2):79-84. PubMed ID: 29045948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.
    Noh SH; Park SR; Yang HK; Chung HC; Chung IJ; Kim SW; Kim HH; Choi JH; Kim HK; Yu W; Lee JI; Shin DB; Ji J; Chen JS; Lim Y; Ha S; Bang YJ;
    Lancet Oncol; 2014 Nov; 15(12):1389-96. PubMed ID: 25439693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of preoperative lymphocyte to monocyte ratio on the prognosis of the elderly patients with stage II(-III( gastric cancer].
    Cong X; Li S; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1144-1148. PubMed ID: 27781252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.